Price $21.92 |
Market Cap
59.6M
|
Sector Health Care |
Div. Growth
12.50%
|
|
P/E
14.4
|
P/B
1.22
|
P/S
0.38
|
Dividend %
3.50%
|
|
P/CF
65.8
|
P/FCF
23.1
|
Op. Cash Flow
8.4K
|
FCF
0.9
|
|
Op. Margin
3.80%
|
Net Margin
2.70%
|
ROE
8.70%
|
ROI
11.60%
|
|
ROA
5.10%
|
EPS Growth
-18.80%
|
Current Ratio
2.3
|
Debt/Equity
2.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| R1 RCM Inc (RCM) | $11.80 | - | - | 1.32B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.10 | - | - | 87.4M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $5.78 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $51.31 | - | - | 1.31B | Strong Buy |
| TearLab Corp (TEAR) | $0.09 | - | - | 1.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
